673 related articles for article (PubMed ID: 21864625)
1. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations.
Taitel M; Cohen E; Duncan I; Pegus C
Vaccine; 2011 Oct; 29(45):8073-6. PubMed ID: 21864625
[TBL] [Abstract][Full Text] [Related]
2. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
3. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897
[TBL] [Abstract][Full Text] [Related]
4. An emergency department-based vaccination program: overcoming the barriers for adults at high risk for vaccine-preventable diseases.
Rimple D; Weiss SJ; Brett M; Ernst AA
Acad Emerg Med; 2006 Sep; 13(9):922-30. PubMed ID: 16902048
[TBL] [Abstract][Full Text] [Related]
5. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.
Ridda I; Lindley IR; Gao Z; McIntyre P; Macintyre CR
Vaccine; 2008 Oct; 26(44):5633-40. PubMed ID: 18706955
[TBL] [Abstract][Full Text] [Related]
6. Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years--United States, 2004-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(39):1065-8. PubMed ID: 17021591
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
8. Influenza and pneumococcal immunization rates among a high-risk population.
Chan-Tack KM
South Med J; 2001 Mar; 94(3):323-4. PubMed ID: 11284519
[TBL] [Abstract][Full Text] [Related]
9. Influenza and pneumococcal vaccination in older veterans: results from the behavioral risk factor surveillance system.
Chi RC; Reiber GE; Neuzil KM
J Am Geriatr Soc; 2006 Feb; 54(2):217-23. PubMed ID: 16460371
[TBL] [Abstract][Full Text] [Related]
10. Facilitating influenza and pneumococcal vaccination through standing orders programs.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Jan; 52(4):68-9. PubMed ID: 12578325
[TBL] [Abstract][Full Text] [Related]
11. The role of pharmacists in the delivery of influenza vaccinations.
Steyer TE; Ragucci KR; Pearson WS; Mainous AG
Vaccine; 2004 Feb; 22(8):1001-6. PubMed ID: 15161077
[TBL] [Abstract][Full Text] [Related]
12. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
13. Public health and aging: influenza vaccination coverage among adults aged > or =50 years and pneumococcal vaccination coverage among adults aged > or =65 years--United States, 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Oct; 52(41):987-92. PubMed ID: 14561957
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a toolkit to introduce standing orders for influenza and pneumococcal vaccination in adults: a multimodal pilot project.
Nowalk MP; Nutini J; Raymund M; Ahmed F; Albert SM; Zimmerman RK
Vaccine; 2012 Sep; 30(41):5978-82. PubMed ID: 22835736
[TBL] [Abstract][Full Text] [Related]
15. Influenza and pneumococcal vaccination levels among persons aged > or = 65 years--United States, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Jun; 50(25):532-7. PubMed ID: 11446571
[TBL] [Abstract][Full Text] [Related]
16. [Pneumococcal vaccination for persons 65 years of age and older].
van den Bosch WJ
Ned Tijdschr Geneeskd; 2002 May; 146(18):838-9. PubMed ID: 12038219
[TBL] [Abstract][Full Text] [Related]
17. Eight years of active proposal of pneumococcal 23-valent polysaccharide vaccine: survey on coverage rate among elderly and chronic patients.
Martinelli D; Tafuri S; Caputi G; Fortunato F; Reggio P; Germinario C; Prato R
Am J Infect Control; 2010 May; 38(4):e8-e15. PubMed ID: 20211508
[TBL] [Abstract][Full Text] [Related]
18. Using the National Health Interview Survey: time trends in influenza vaccinations among targeted adults.
Pleis JR; Gentleman JF
Eff Clin Pract; 2002; 5(3 Suppl):E3. PubMed ID: 12166924
[TBL] [Abstract][Full Text] [Related]
19. State-specific influenza vaccination coverage among adults aged > or =18 years--United States, 2003-04 and 2005-06 influenza seasons.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(37):953-9. PubMed ID: 17882124
[TBL] [Abstract][Full Text] [Related]
20. Expanding the recommendations for annual influenza vaccination to school-age children in the United States.
Fiore AE; Epperson S; Perrotta D; Bernstein H; Neuzil K
Pediatrics; 2012 Mar; 129 Suppl 2():S54-62. PubMed ID: 22383482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
